Literature DB >> 19018679

Thiazide-induced dysglycemia: it's time to take notice.

Rhonda M Cooper-DeHoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19018679      PMCID： PMC3891644          DOI： 10.1586/14779072.6.10.1291

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN： 1477-9072


× No keyword cloud information.
  23 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Cardiovascular therapies and risk for development of diabetes.

Authors:  Carl J Pepine; Rhonda M Cooper-Dehoff
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

Review 3.  Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.

Authors:  Barry L Carter; Paula T Einhorn; Michael Brands; Jiang He; Jeffrey A Cutler; Paul K Whelton; George L Bakris; Frederick L Brancati; William C Cushman; Suzanne Oparil; Jackson T Wright
Journal:  Hypertension       Date:  2008-05-26       Impact factor: 10.190

4.  Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.

Authors:  George Davey Smith; Yiscah Bracha; Kenneth H Svendsen; James D Neaton; Steven M Haffner; Lewis H Kuller
Journal:  Ann Intern Med       Date:  2005-03-01       Impact factor: 25.391

5.  National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.

Authors:  Kelly J Hunt; Roy G Resendez; Ken Williams; Steve M Haffner; Michael P Stern
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium.

Authors:  J H Helderman; D Elahi; D K Andersen; G S Raizes; J D Tobin; D Shocken; R Andres
Journal:  Diabetes       Date:  1983-02       Impact factor: 9.461

8.  Lifetime risk for diabetes mellitus in the United States.

Authors:  K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

9.  Adverse prognostic significance of new diabetes in treated hypertensive subjects.

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Fabio Angeli; Claudia Borgioni; Roberto Gattobigio; Lucia Filippucci; Silvia Norgiolini; Costanza Bracco; Carlo Porcellati
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190

10.  Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

Authors:  Lars H Lindholm; Hans Ibsen; Knut Borch-Johnsen; Michael Hecht Olsen; Kristian Wachtell; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan M Edelman; Steven Snapinn
Journal:  J Hypertens       Date:  2002-09       Impact factor: 4.844
View more
  5 in total

Review 1.  A review of the prescribing trend of thiazide-type and thiazide-like diuretics in hypertension: A UK perspective.

Authors:  Ryan J McNally; Franca Morselli; Bushra Farukh; Philip J Chowienczyk; Luca Faconti
Journal:  Br J Clin Pharmacol       Date:  2019-12-09       Impact factor: 4.335

Review 2.  Type 2 Diabetes and Thiazide Diuretics.

Authors:  André J Scheen
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

3.  Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.

Authors:  Mariellen J Moore; Yan Gong; Wei Hou; Karen Hall; Siegfried O F Schmidt; Robert Whitney Curry; Amber L Beitelshees; Arlene Chapman; Stephen T Turner; Gary L Schwartz; Kent Bailey; Eric Boerwinkle; John G Gums; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2014-09-09       Impact factor: 4.705

4.  Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.

Authors:  Rhonda M Cooper-DeHoff; Sheron Wen; Amber L Beitelshees; Issam Zineh; John G Gums; Stephen T Turner; Yan Gong; Karen Hall; Vishal Parekh; Arlene B Chapman; Eric Boerwinkle; Julie A Johnson
Journal:  Hypertension       Date:  2009-11-16       Impact factor: 10.190

5.  Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients.

Authors:  Sonal Singh; Caitrin W McDonough; Yan Gong; Wael A Alghamdi; Meghan J Arwood; Salma A Bargal; Leanne Dumeny; Wen-Yi Li; Mai Mehanna; Bradley Stockard; Guang Yang; Felipe A de Oliveira; Natalie C Fredette; Mohamed H Shahin; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; John G Gums; Stephen T Turner; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  J Am Heart Assoc       Date:  2018-03-09       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.